Second Sight Medical Products, Inc. (EYES): Price and Financial Metrics

Second Sight Medical Products, Inc. (EYES): $4.14

0.22 (-5.05%)

POWR Rating

Component Grades

Momentum

D

Stability

C

Sentiment

Quality

D

EYES Price/Volume Stats

Current price $4.14 52-week high $12.72
Prev. close $4.36 52-week low $3.42
Day low $4.14 Volume 36,800
Day high $4.35 Avg. volume 132,982
50-day MA $5.84 Dividend yield N/A
200-day MA $5.22 Market Cap 54.38M

EYES Stock Price Chart Interactive Chart >


Second Sight Medical Products, Inc. (EYES) Company Bio


Second Sight Medical Products develops, manufactures, and markets implantable prosthetic devices to restore functional vision to blind patients in the United States, Canada, Europe, and Saudi Arabia. The company was founded in 1998 and is based in Sylmar, California.


EYES Latest News Stream


Event/Time News Detail
Loading, please wait...

EYES Latest Social Stream


Loading social stream, please wait...

View Full EYES Social Stream

Latest EYES News From Around the Web

Below are the latest news stories about SECOND SIGHT MEDICAL PRODUCTS INC that investors may wish to consider to help them evaluate EYES as an investment opportunity.

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday

We're starting the final day of trading this week with a look at the biggest pre-market stock movers for Friday and what's moving them!

William White on InvestorPlace | August 19, 2022

Second Sight Medical Products, Inc. Announces Shareholder Approval for Proposed Merger with Nano Precision Medical, Inc. and other Results of 2022 Annual Meeting

LOS ANGELES, July 29, 2022--Second Sight Medical Products, Inc. (NASDAQ: EYES) (the "Company" or "Second Sight"), a leading developer of implantable visual prosthetics that are intended to create an artificial form of useful vision for blind individuals, today announced results of its annual meeting held on July 27, 2022, where the quorum was present. The formal results of the vote are included in a Current Report on Form 8-K filed by the Company with the Securities and Exchange Commission.

Yahoo | July 29, 2022

Second Sight Medical Products Announces Year Four NIH Funding of its Orion Study

LOS ANGELES, July 18, 2022--Second Sight Medical Products, Inc. (NASDAQ: EYES) (the "Company" or "Second Sight"), a leading developer of implantable visual prostheses that are intended to create an artificial form of useful vision for blind individuals, today announced that the Company received notice from the National Institutes of Health ("NIH") of the release of year four funding for its Early Feasibility Clinical Trial of a Visual Cortical Prosthesis (the "Orion Trial"), grant 5UH3NS103442.

Yahoo | July 18, 2022

Nano Precision Medical Co-Founder and CEO Discusses Proposed Second Sight Merger in Interview to Air on Bloomberg U.S. on the RedChip Money Report®

LOS ANGELES, April 14, 2022--Second Sight Medical Products, Inc. (NASDAQ: EYES) ("Second Sight"), a recognized global leader in neuromodulation devices for blindness, today announced that an interview with Adam Mendelsohn, Ph.D., Co-Founder and CEO of Nano Precision Medical, Inc. ("NPM"), will air on The RedChip Money Report® on Bloomberg US on April 16 at 7 p.m. Eastern Time (ET). Bloomberg US is available in an estimated 73 million homes across the United States.

Yahoo | April 14, 2022

EYES Stock Pops on Biotech Merger Plans. 5 Things to Know.

Second Sight Medical (NASDAQ:EYES) stock is up 15% this morning after announcing a merger with Nano Precision. Source: Shutterstock So what do you need to know? To start, Second Sight Medical is acquiring Nano Precision through an all-stock deal. As part of this, it will issue 134 million shares. Current EYES stock holders will own roughly 23% of the combined company. Right now, Second Sight expects the deal to close by the end of the third quarter. Before it does, it will be subject to stockhol

Yahoo | February 8, 2022

Read More 'EYES' Stories Here

EYES Price Returns

1-mo N/A
3-mo N/A
6-mo N/A
1-year N/A
3-year -81.25%
5-year -81.25%
YTD N/A
2023 N/A
2022 0.00%
2021 -12.83%
2020 -68.50%
2019 -16.63%

Continue Researching EYES

Want to see what other sources are saying about Second Sight Medical Products Inc's financials and stock price? Try the links below:

Second Sight Medical Products Inc (EYES) Stock Price | Nasdaq
Second Sight Medical Products Inc (EYES) Stock Quote, History and News - Yahoo Finance
Second Sight Medical Products Inc (EYES) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!